NO982441D0 - Measurement of drug doses, therapeutics and other glycosaminoglycans (GAGS) - Google Patents

Measurement of drug doses, therapeutics and other glycosaminoglycans (GAGS)

Info

Publication number
NO982441D0
NO982441D0 NO982441A NO982441A NO982441D0 NO 982441 D0 NO982441 D0 NO 982441D0 NO 982441 A NO982441 A NO 982441A NO 982441 A NO982441 A NO 982441A NO 982441 D0 NO982441 D0 NO 982441D0
Authority
NO
Norway
Prior art keywords
gags
glycosaminoglycans
therapeutics
measurement
drug doses
Prior art date
Application number
NO982441A
Other languages
Norwegian (no)
Other versions
NO982441L (en
Inventor
Stefan Gustafson
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002164260A external-priority patent/CA2164260C/en
Priority claimed from CA 2173037 external-priority patent/CA2173037A1/en
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Publication of NO982441D0 publication Critical patent/NO982441D0/en
Publication of NO982441L publication Critical patent/NO982441L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO982441A 1995-12-01 1998-05-28 Measurement of drug doses, therapeutics and other glycosaminoglycans (GAGS) NO982441L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002164260A CA2164260C (en) 1995-12-01 1995-12-01 Targeting of dosages of medicines and therapeutic agents
CA 2173037 CA2173037A1 (en) 1996-03-29 1996-03-29 Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags)
PCT/CA1996/000793 WO1997020564A1 (en) 1995-12-01 1996-11-29 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)

Publications (2)

Publication Number Publication Date
NO982441D0 true NO982441D0 (en) 1998-05-28
NO982441L NO982441L (en) 1998-05-28

Family

ID=25678243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982441A NO982441L (en) 1995-12-01 1998-05-28 Measurement of drug doses, therapeutics and other glycosaminoglycans (GAGS)

Country Status (11)

Country Link
EP (1) EP0869798A1 (en)
JP (1) JP2000513707A (en)
KR (1) KR19990071628A (en)
AU (1) AU727001B2 (en)
BR (1) BR9611671A (en)
HU (1) HUP9901935A3 (en)
IL (1) IL124647A0 (en)
MX (1) MX9804343A (en)
NO (1) NO982441L (en)
PL (1) PL326970A1 (en)
WO (1) WO1997020564A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (en) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl SULPHATED POLYSACCHARIDES
CN100374163C (en) 1999-01-13 2008-03-12 阿尔凯米亚肿瘤学私人有限公司 Composition and method for the enhancement of the efficacy of drugs
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
CN103784960A (en) * 2005-07-27 2014-05-14 阿尔卡米亚肿瘤学股份有限公司 Therapeutic protocols using hyaluronan
CA2621279C (en) 2005-09-07 2016-06-14 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
AUPM714794A0 (en) * 1994-07-29 1994-08-18 International Fluid Separation Pty Limited Separation apparatus and method
JPH10504828A (en) * 1994-08-30 1998-05-12 ハイアル ファーマスティカル コーポレイション Hyaluronic acid and its derivatives for regulating cell activity

Also Published As

Publication number Publication date
EP0869798A1 (en) 1998-10-14
BR9611671A (en) 1999-12-28
PL326970A1 (en) 1998-11-09
MX9804343A (en) 1998-09-30
AU7687896A (en) 1997-06-27
HUP9901935A3 (en) 2001-04-28
HUP9901935A2 (en) 1999-11-29
IL124647A0 (en) 1998-12-06
JP2000513707A (en) 2000-10-17
WO1997020564A1 (en) 1997-06-12
KR19990071628A (en) 1999-09-27
NO982441L (en) 1998-05-28
AU727001B2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
EE9900075A (en) 7α- (-aminoalkyl) oestratrienes, process for their preparation, pharmaceutical preparations containing 7α- (-aminoalkyl) oestratrienes and their use in the manufacture of medicaments
IT8847556A0 (en) PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
NO965376D0 (en) Pharmaceutical preparations and methods for formulating signal transduction
NO303638B1 (en) Condensed indole derivatives, pharmaceutical preparations containing them and the use of the derivatives
FI973278A0 (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical preparations containing them
PL312829A1 (en) Novel derivatives of naphtalene and method of obtaining them, novel intermediate compounds and pharmaceutical agent
IS4557A (en) Use of fumagillol and its derivatives in the manufacture of anti-inflammatory drugs
NO308740B1 (en) Quinazoline derivatives, their use and pharmaceutical admixture
FI933472A (en) Peptides for the production of inhibitory effects in HIV proteas, for the development and therapeutic use of HIV
IT8947823A0 (en) PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
AP9100285A0 (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
NO930226D0 (en) Cephalosporins and Homologs, Preparations and Pharmaceutical Preparations
NO900276L (en) NEW BENZOPYRANE DERIVATIVES, THEIR PREPARATION AND USE OF PHARMACEUTICAL PREPARATIONS.
EE9600172A (en) Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments
NO911956L (en) PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS
IS3951A (en) Cephalosporin derivatives, their method of manufacture and use as pharmaceuticals
NO982441D0 (en) Measurement of drug doses, therapeutics and other glycosaminoglycans (GAGS)
IT8948682A0 (en) CAPSAICIN DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES (CASE 700-0062)
NO305286B1 (en) Quinoxaline compounds, pharmaceutical preparations comprising them, and their use in the manufacture of medicaments
ITMI912261A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CLOZAPINE, THEIR PREPARATION AND THEIR USE
IT1227436B (en) DERIVATIVES OF 1-AZABICICLOALCANI, THEIR PREPARATION PROCEDURE AND THEIR APPLICATION AS DRUGS
GB2243550B (en) Pharmaceutical anti-fungal use of cholane derivatives
DK0869952T3 (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxanes, preparation and therapeutic use thereof
NO305792B1 (en) Substituted benzenesulfonylureas, their use in the preparation of pharmaceutical preparations and drugs containing them